2023 News & Press Releases Applied BioCode Announces Retirement of CEO Chris Bernard 03/22/2024 Applied BioCode announced today the retirement of Chris Bernard as Chief Executive Officer. Chris Bernard has served as CEO for … Read More
2023 News & Press Releases Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer 09/28/2023 Applied BioCode announced today that Beth Laderman has been appointed as their new Chief Scientific Officer (CSO) signaling a significant … Read More
2023 News & Press Releases Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use 06/13/2023 Applied BioCode now offers Fungal Panel on the BioCode® MDx-3000 system for research use only (RUO). The Fungal Panel Assay … Read More
2023 News & Press Releases Applied BioCode Announces Distribution Agreement with Medline Industries 05/08/2023 Applied BioCode today announced an agreement with Medline Industries, a leading manufacturer and distributor of healthcare products, to distribute the … Read More
2023 News & Press Releases How to Improve Accessibility to Testing for GI Infections 03/22/2023 Infectious diarrhea also known as gastroenteritis, is a leading cause of death worldwide and a serious health risk to the … Read More
2023 News & Press Releases Applied BioCode Announces 2022 Q4 and Full year Revenue 02/28/2023 Strong Growth in Multiplex IVD and Steady Contribution from Technology Platform Partnerships February 27, 2023 8:47 AM Eastern Standard Time … Read More
